公司简介

DermTech is the global leader in molecular dermatology, bringing precision medicine to the diagnosis and treatment of skin disease. We market and develop products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments.

主要成员

Gary Jacobs、Burkhard Jansen、John Dobak、John Alsobrook

产品/服务

• 肿瘤基因组
• 科技服务

Non-melanoma skin cancers

Include basal and squamous cell carcinomas.

Pigmented Lesion Assay

DermTech’s Pigmented Lesion Assay (PLA) assesses gene expression consistent with melanoma and can aid in the clinician’s biopsy decision.

融资信息

融资轮次	融资日期	投资方	融资额度
创业	1998-06	未披露	undisclosed amount
创业	2008-03	未披露	$11.16M
创业	2012-04	未披露	$11.58M
B轮	2013-08	未披露	$5.6M
债务融资	2015-04	未披露	$2.44M
创业	2015-11	未披露	$4.31M
创业	2016-10	未披露	$2.07M
C轮	2017-11	未披露	千万美元

关联公司